A detailed history of Breed'S Hill Capital LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Breed'S Hill Capital LLC holds 3,582 shares of MRK stock, worth $300,601. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,582
Previous 4,456 19.61%
Holding current value
$300,601
Previous $400 Million 29.11%
% of portfolio
0.14%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$73.47 - $87.12 $64,212 - $76,142
-874 Reduced 19.61%
3,582 $284 Million
Q1 2025

May 14, 2025

SELL
$83.01 - $101.02 $95,959 - $116,779
-1,156 Reduced 20.6%
4,456 $400 Million
Q4 2024

Feb 18, 2025

BUY
$96.31 - $114.76 $129,922 - $154,811
1,349 Added 31.64%
5,612 $558 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $31,933 - $37,209
-282 Reduced 6.2%
4,263 $563 Million
Q4 2023

Feb 06, 2024

BUY
$100.18 - $109.02 $455,318 - $495,495
4,545 New
4,545 $495 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $213B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Breed'S Hill Capital LLC Portfolio

Follow Breed'S Hill Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Breed'S Hill Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Breed'S Hill Capital LLC with notifications on news.